The preparation and characterization by LCMS of a library of 55 fluorescencequenched peptides is described. The peptides bear a terminal anthranilamide fluorophore and a penultimate 2,4-dinitrophenyl-L-lysine quencher, and will be used to probe the substrate binding domain of the human blood coagulation enzyme, factor Xa.
Introduction
Factor Xa is an arginine-specific serine protease that operates at the convergence of the extrinsic and intrinsic blood coagulation pathways [1] . The prothrombinase complex, which consists of factors Xa and Va, phospholipid and calcium, is responsible for limited proteolysis of prothrombin to give thrombin. These facts, along with factor Xa's relatively specific physiological role [2] , make it a prime target for the development of new selective anticoagulants. Intimate knowledge of the protein sequences most preferred by factor Xa provides insight into the enzyme's physiological role, its interaction with natural inhibitors and allows more effective design of selective anticoagulants. Most peptidic inhibitors of serine proteases have been designed to associate with the substrate binding sites on the N-terminal ("non-prime") side of the cleavage site [3] . However, inhibitors that associate with the enzyme on both sides of the catalytic serine [4] have the potential to bind more strongly and be more selective between related proteases.
We have previously probed the selectivity of bovine factor Xa for the first three substrate amino acid residues on the "prime" side of the cleavage site, P 1 ', P 2 ' and P 3 ' [5] . Fluorescence quenched peptide substrates [6] spanning both sides of the scissile bond (P 1 -P 1 ') were used to investigate such P' specificities in a similar way to that used for other proteases [7, 8] . These probes contain an N-terminal 2-aminobenzoyl (Abz) group and a penultimate 2,4-dinitrophenyl (Dnp) derivitized lysine (e.g. 1, Figure 1 ). The fluorescence of the N-terminal Abz group (λ ex = 325 nm, λ em = 414 nm) is quenched in the intact peptides by the Dnp group through intramolecular resonance energy transfer [6] . Peptide hydrolysis by factor Xa relieves this intramolecular fluorescence quenching and the resulting increase in fluorescence is proportional to the concentration of the released fluorophoric fragment (2) . This enables determination of kinetic parameters by monitoring the change in fluorescence intensity with time. in the peptidic probes is relieved on cleavage, adjacent to the arginine residue, by the protease, factor Xa.
Results and Discussion
While peptidic probes of the type mentioned above have been sited a number of times in the biological literature, a detailed description of the preparation and characterization of such compounds, as well as their precursors, N-(Boc)-anthranilic acid and N 2 -Fmoc-N 6 -dinitrophenyl-L-lysine, has yet to appear. In this article, we provide a comprehensive description of the preparation of a library of peptidic fluorescence-quenched probes that are being used to probe the "prime-side" substrate specificities of human factor Xa. The biological results obtained with these probes will be published at a later date.
Substrates suitable for the present study were prepared using parallel solid phase peptide synthesis techniques incorporating Fmoc/HBTU/TFA chemistry (see General Experimental section for a list of abbreviations used in this article) and is summarised in Scheme 1. Briefly, this involved building the peptides on a solid phase bearing a HMPA linker, with aspartate attached through the side chain carboxylic acid and Fmoc-protected on the nitrogen, and with the α-carboxylic acid protected with a tert-butyl group.
Scheme 1.
The Fmoc protecting group was removed with piperidine and the next amino acid, with Fmoc and side chain protection, was attached with HBTU activation. The terminal Fmoc group was then cleaved, again with piperidine, and the two-step process was repeated with the next protected amino acid until the desired sequence was obtained. The peptide was then cleaved from the resin, and the amino acid side chain protecting groups removed, by treatment with TFA in the presence of anisole and EDT. Where coupling steps were found to be low yielding, a "double coupling" was performed, in which the solid phase was treated twice with the activated amino acid prior to Fmoc removal. In some cases, it was also necessary to re-treat the cleaved peptides with TFA to remove the last traces of tertbutyl side-chain protecting groups. This overall strategy typically allowed the production of peptides in >60% yield and >90% purity (see Tables 2 -4) .A library of 55 fluorescence-quenched peptides was prepared with the sequence being; Abz-Ile-Glu-Gly-Arg-P 1 '-P 2 '-P 3 '-Ser-Lys(Dnp)-Asp-OH (1). The most common naturally occurring amino acids, excluding cysteine, were substituted at the P 1 ', P 2 ' or P 3 ' positions while the remainder of the sequence was unchanged, with alanine being used as the default residue for the P 1 '-P 3 ' positions.
Conclusions
We have presented a detailed description of the preparation and characterization of a library of 55 fluorescence-quenched peptidic probes for use in determination of the "prime-side" substrate specificities of human factor Xa. More than 87% of these peptides were obtained in >60% yield and all were obtained in >90% purity, as judged by LCMS. 300MHz spectrometer ( 1 H-, 300 MHz; 13 C-, 75 MHz). The spectra were run at ambient temperature using the appropriate deuterated solvent with all chemical shifts referenced to the residual protonated solvent peak. Chemical shifts (δ) are reported in parts per million (ppm), followed by their multiplicities, coupling constants (J Hz) where appropriate, intensities and assignments. Infrared spectra were recorded using a Perkin Elmer 1600 Series Fourier Transform Spectrophotometer. The spectra of oils were recorded as thin films (neat) mounted on NaCl plates, whereas solids were recorded as either nujol mulls on NaCl plates or as KBr disks. Principal diagnostic absorptions are reported in wavenumbers (cm -1 ) followed by assignment were appropriate. All mass spectra used are electrospray ionisation (ESI ) unless otherwise stated. High resolution mass spectra were recorded on a Bruker BioApex 47e Fourier Transform mass spectrometer. Samples were dissolved in methanol or 1:4 dichloromethane -methanol, and ionized using an ESI source. Melting points of solid compounds were measured on a Reichert hot stage melting point apparatus and are uncorrected. Flash chromatography refers to wet-packed columns with Merck silica gel 60 (0.040-0.063 mm, 230-400 mesh ASTM) as the stationary phase. Pre-absorption was carried out using the same silica. Air pressure was applied to columns to give an approximate flow rate of 2. 
Following the procedure of Anastasi et al. [9] , diisopropylethylamine (1.5 mL, 8.6 mmol) was added to commercial N 6 -dinitrophenyl-L-lysine (1.50 g, 4.3 mmol) in 1:1 acetonitrile/water (22 mL).
The resulting solution was stirred vigorously at 0°C and Fmoc-succinimidyl carbonate (1.50 g, 4.4 mmol) was added over 25 minutes. After a further 30 minutes, the reaction mixture was allowed to warm to room temperature and left to stir for 20 hours. The reaction mixture was then diluted with ethyl acetate (100 mL) and the organic phase washed with 10% citric acid (100 mL), water (3 x 100 mL) and saturated NaCl (100 mL). 
2-Amino(tert-butoxycarbonyl)benzoic acid
Following the method of Mougenot and Marchand-Brynaert [10] NaOH (0.65 g, 16.5 mmol), in water (16 mL) and tert-butanol (22 mL), was added to anthranilic acid (2.05 g, 14.9 mmol). Di-tertbutyl dicarbonate (3.23 g, 14.8 mmol) was then added with vigorous stirring over 15 minutes. The reaction was left to stir at room temperature for 17 hours after which time it was cooled to 0°C and acidified to pH 2-3 with citric acid (10% w/v). The reaction mixture was then extracted with ether (2 x 100 mL then 2 x 50 mL) and the combined organic extracts were dried over MgSO 4 
General Procedure for the Synthesis of Individual Fluorescence Quenched Peptides
Peptides were prepared following the Mimotopes procedures [12] with some modifications. These modifications allowed the use of HBTU as the activating agent, in place of BOP. All solvents/reagents were dried and purified as specified [12] . Mimotopes Series I crowns bearing HMPA linkers and an Fmoc protected Asp residue (which formed the C-terminus of the completed peptides) were the starting point of the synthesis of all peptides. These crowns conveniently fit into 1.6 mL Eppendorf tubes, which were used as reaction vessels for the Fmoc-deprotection, coupling and washing steps.
Fmoc Deprotection
Each crown was immersed in 20% piperidine/DMF (750 µL) for 20 minutes. The crown was then washed several times, firstly with DMF (750 µL) for 2 minutes, then with methanol (3 x 750 µL) also for 2 minutes each. The crowns were then allowed to dry at room temperature on a watchglass for 30 minutes.
Amino Acid and Activation Solutions
The desired L-amino acid with N-Fmoc protection (0.116 mmol, see Table 1 
Amino Acid Coupling
The Fmoc-L amino acid solution (310 µL of the 320 µL) was added to the activating solution (490 µL of the 510 µL) to give a coupling solution (800 µL) containing Fmoc-L-amino acid (140 mM), HBTU (140 mM), HOBt.H 2 O (140 mM) and NMM (210 mM). After 2 minutes, the dry deprotected crown was immersed in the coupling solution and left to stand for at least 2 hours. The crowns were then removed and washed with methanol (750 µL) for 5 minutes, dried at room temperature for 2 minutes and then washed with DMF (750 µL) for 5 minutes. The crown was then subjected to repeated cycles of the above deprotection and coupling steps to give the amino acid sequence required. An alternative post-coupling washing procedure was used when the next cycle could not be started immediately. This involved the crown being washed with DMF (750 µL) for 5 minutes, dried for 2 minutes and then washed with methanol (750 µL) for 5 minutes. After drying, the crown was stored at room temperature in a covered petri dish until needed.
Side Chain Deprotection and Cleavage
After coupling of the final residue, Abz in this case, the crown was washed with DMF (750 µL) for 2 minutes, then with methanol (2 x 750 µL) for 2 minutes each and allowed to air dry for 30 minutes. The crown was then placed in a 10 mL plastic centrifuge tube containing the cleavage solution, which consisted of TFA (1.24 mL), EDT (37.5 µL), anisole (75 µL), thioanisole (75 µL) and water (75 µL). After 2.5 hours, the crown was then removed and washed with TFA (0.5 ml). The TFA wash was then added to the peptide solution that remained in the centrifuge tube and the mixture was concentrated to ~10% volume under a flow of nitrogen gas (~2 hours).
Trituration
To the concentrated peptide solution was added a solution of 1:2:0.1% ether/hexane/ mercaptoethanol (8 mL) and the mixture was shaken. The suspension was placed in a freezer (approx. -20°C) for 30 minutes, centrifuged and the supernatant decanted from the solid. Additional 1:2 ether/hexane (4 mL) solution was added and again shaken, cooled, centrifuged and the supernatant removed. The resulting pellet was dried under nitrogen, suspended in H 2 O and freeze-dried to give the desired peptide typically in quantitative yield. The purity of the product was determined using LCMS. 
Synthesis of P 1 '-P 3 ' Fluorescence Quenched Substrate Library
The factor Xa P 1 ', P 2 ' and P 3 ' library consisted of 55 peptides. All had the sequence Abz-Ile-GluGly-Arg-P 1 '-P 2 '-P 3 '-Ser-Lys(Dnp)-AspOH were P 1 ', P 2 ' and P 3 ' were varied individually using alanine as the default residue. The procedure for the synthesis of these probes followed the "General Procedure for the Synthesis of Individual Fluorescence Quenched Peptides" (above) with the following exceptions: Following the coupling of the P 1 ' amino acid, and before Fmoc removal, the crowns were subjected to a second immersion in fresh coupling solution (containing the activated P 1 ' amino acid) followed by the appropriate washes, before the next deprotection and coupling cycles were undertaken. In addition, instead of individual eppendorf tubes, a reaction tray containing 96 wells was utilized in conjunction with a pin holder on which crowns attached to stems were mounted. All Fmocdeprotection, coupling, washes and drying was undertaken with the crowns attached to the pin holder. This allowed efficient synthesis of the large number of peptides in parallel. Side chain deprotection and cleavage was still performed in individual centrifuge tubes. To allow for the smaller reaction vessels in the 96-well plate, quantities used differed as follows: The deprotection and washing steps all used 700 µL. The amino acid solution contained 0.102 mmol (rather than the 0.116 mmol quantities listed in Table 1 (210 mM), to which the crown was added. The peptidic products were individually cleaved from the crowns and triturated in 10 mL plastic centrifuge tubes in the same way as that described above for the preparation of individual peptides. The yields obtained are shown in Tables 2-4 . Characterisation by LCMS in most cases identified the major constituent to be the desired peptide, as indicated by the retention time and m/z reported in the Tables. For some peptides, however, a second peak, which was identified as the desired peptide with a t-butyl group still attached was also observed in the LCMS chromatogram. In these cases, a second treatment with the TFA cleavage solution, followed by trituration and freeze-drying, completed the deprotection of the peptides ensuring that they were obtained in greater than 90% purity. In some cases, initial LCMS analysis also revealed the presence of another ion, which was apparently due to fragmentation of the peptide in the mass spectrometer. These latter ions corresponded to the doubly protonated peptide having lost the 2 N-terminal residues (AbzIle). 
